Valentina Cauda is Associate Professor at the Department of Applied Science and Technology of the Politecnico di Torino, Italy since May 2016. She received her Ph.D. In Material Science and Technology in 2008 from the same university and graduated in Chemical Engineering in 2004. In 2006 she worked as visiting PhD student at the Universidad Complutense of Madrid, Spain in the research group of Prof. Maria Vallet-Regí. From 2008 to 2010, she worked as a Post-Doc at the Faculty of Chemistry, University of Munich, Germany in the group of Prof. Thomas Bein. From 2010 to 2015 she was Senior Post-Doc at the Istituto Italiano di Tecnologia in Turin, Italy. For her research results she received in 2010 the prize for young researchers at the Chemistry Department of the University of Munich, in 2013 she got the Giovedì Scienza award, in 2015 the Zonta Prize for Chemistry, and in 2017 the USERN Prize for Biological Sciences.In 2016 she was awarded by the European Research Council with an ERC Starting Grant entitled “TrojaNanoHorse”. She is author of 80 papers on peer-reviewed international journals with an H-index of 28 (Source: Scopus accessed on January 2018).
Paula Marques (born 1969) has a first degree in Chemistry (1993), a MSc in Chemistry and Physics Teaching (1997) and a PhD in Materials Science Engineering, with specialization in Biomaterials (2003) from the University of Aveiro (UA) in Portugal.
Paula is a Principal Researcher at TEMA – Centre for Mechanical Technology and Automation, Mechanical Engineering Department, UA. Currently is the Deputy-Director for Society and Social Responsibility in the Department of Mechanical Engineering and Sub-Director of the research unit TEMA (Centre of Mechanical Technology and Automation) board of Directors, responsible for new areas of specialization.
Her current research interests include the engineering and development of nanostructured multifunctional materials including graphene derivatives such as: (i) mechanical and electrical stimulus responsive 3D graphene-based scaffolds for tissue engineering; (ii) functional graphene-based macrostructures for water remediation; (iii) electrospun graphene/polymer fibres for photocatalysis; (iv) graphene-based materials as mechanical reinforcement of polymer matrixes.
Paula is author of 77+ original research or review papers in international journals (2900+ citations, h=28 – Scopus), about 7 book chapters, 2 books and 3 patents. Paula has been invited to review manuscripts from 30+ different international journals and to evaluate projects from Cost and Era-Net funding agencies. Paula supervised or co-supervised 10 MSc, 12 PhD students, and 8+ post-doctoral fellows. Since April 2019 she is coordinating a FET Open H2020 project, “NeuroStimSpinal: A Step Forward to Spinal Cord Injury Repair Using Innovative Stimulated Nanoengineered Scaffolds". She is also coordinating and co-coordinating several Portuguese Projects obtaining under competitive funding.
Regarding Paula’s pedagogical role, she is the teacher in charge for the 3rd cycle curricular unit Carbon Nanostructures, and teacher of the 2nd cycle curricular unit Technologies and Processes at Nanoscale.
Hans Jörg Meisel MD PhD is now the Director of the Center of Neurosciences/Chair Dept.of Neurosurgery, BG-Clinic Bergmannstrost Halle-Donau-Universität Krems-Vrije Universiteit Medical Center (VUmc) Amsterdam-Translational Centre for Regenerative Medicine (TRM) Leipzig-President Regenerate Europe e.V.
In 1998 HJ. Meiselwas appointed to the Berufsgenossenschaftliche Clinic in Bergmannstrost Halle/Saale as Director of the Clinic for Neurosurgery. Every year his team of 10 surgeons carries out a minimum of 1800 surgeries in the area of cerebral and spinal diseases.Since September 2008 HJ. Meisel has been appointed as the Director of the Center of Neurosciences of the BG-Clinic Bergmannstrost Halle. HJ. Meiselsprimary focus in spine surgery and research is for the last 20 years in degenerative spinal diseases. Starting as inventor and designer of spinal implants for the intervertable space in cervical and lumbar in arthroplasty and fixation hedeveloped 1995the first biological disc repair transplantation system with autologus chondrocytes.HJ.Meisel served as a PI for the first randomized clinical trial to study this regenerative approach (EuroDisc) after running all preclinical evaluations at Emory Spine Center, Atlanta. Together with hisAtlantagroup theycontinued the preclinical and clinical work in disc regeneration with adiposed derived mesenchymal stem cells.As a founding member HJ. Meiselhelped to start the ETP Platform Nanomedicine for the European Commission. From 2003 to 2006 HJ.MeiselservedAOSpine Europeas a founding member andto develop a new teaching and course platform as a deputy on the neurosurgical side. (Intervertable Disc Course Davos, 2005; Strasbourg Course 2006; Cervical Course Palma de Mallorca, 2006)In 2005 HJ.Meiselco-founded the Translation Center for Regenerative Medicine at the University of Leipzig and supported there as an Executive Board member the preclinical affairs mentoring since the beginning 4 major spinal projects with the focus in regenerative disc repair and biomaterials financed by the German Ministry of Research (BMBF).In 2005 HJ. Meisel founded the European Network for Regenerative Medicine Regenerate Europewhich integrates 10 countries of the European Union that carry out research in the area of Regenerative Medicine and organized the Biospine Meetings (2002, 2007, 2010) and Regulatory Workshops for ATMPs and animal modeling (2010, 2012, 2014).In 2007 HJ.Meiselwas appointed by the Vreije University of Amsterdam to become a Visiting Professor in the Department of Orthopedic Surgery for the coordination of international research projects and the development of the European Master Degree in Regenerative Medicine.Currently there isrunningthe EU COST project Namabio “From nano to macro biomaterials (design, processing, characterization, modelling) and applications to stem cells regenerative orthopaedic and dental medicine” including 250 members in nanomaterial research and clinical application. In 2013 hebecame an Honorary Professor inthe Department for Health Sciences and Biomedicine at the Donau-University Krems (Austria).In 2013 he became an elected member of the AO Spine Knowledge Forum Degenerative and Biologics. In 2014 he was elected as chair of the European Technology Platform Nanomedicine (ETPN) Working Group of Nanotechnologies for Regenerative Medicine. HJ Meisel is active member of the EANS, SSE, ICRS, ISSLS, ISASS, AOSpine and others.
Dr. Emmanuel Stratakis is a Research Director at the Institute of Electronic structure and laser (IESL) (www.iesl.forth.gr ) of the Foundation for Research and Technology—Hellas (FORTH) (www.forth.gr ). He received his Ph.D. in Physics from the University of Crete in 2001 from the Physics Department, University of Crete. After graduating, he joined as a visiting Researcher the IESL-FORTH working on the ultrafast laser engineering of materials and as an Adjunct Professor at the Department of Materials Science and Technology, University of Crete. In the fall semesters of 2006 and 2008, he was appointed as a visiting Researcher at the Department of Mechanical Engineering of the University of California, Berkeley. In 2007 he was elected Researcher at IESL-FORTH where he is leading the “Ultrafast Laser Micro- and Nano- processing” laboratory (http://stratakislab.iesl.forth.gr / https://www.iesl.forth.gr/en/research/ULNMP-Group). His research interests are in the fields of o (a) Laser-matter interaction; (b) Ultrashort pulsed laser processing of biomimetic surfaces ; (c) Laser processes for organic & hybrid electronics; (d) Laser engineeering and diagnostics of Graphene and related 2D materials ; (e) Advanced photonic processes in photovoltaic and energy storage devices; (f) Photo-assisted synthesis of nanocrystals; (g) Applications on non linear imaging in materials science and biology; (h) Laser assisted biofabrication for tissue engineering applications ; (i) Multipurpose 3D printing complemented with subtractive manufacturing. He has over 220 SCI publications and more than 8000 citations, h-index=48 (Scopus), and he has coordinated many National and EU grants. He has delivered more than 40 invited and keynote lectures and has been organizer and chair in major international scientific conferences. He has been an Editor of the journals ‘Optoelectronic Advances’, ‘Materials Today (Bio)’, ‘Applied Sciences’ and ‘International Journal of molecular Sciences. Since 2015, he is the Director of the Nanoscience Facility of FORTH, part of the NFFA-Europe EU Infrastructure, where he is a member of the General Assembly. He is a National expert in the High-Level Group of EU on Nanotechnologies, Advanced materials, Biotechnology, Advanced Manufacturing and Processing. He is a member of the Scientific Committee of COST. Since January 2020 he is the founder and Chief Executive Officer of Biomimetic (https://www.biomimetic.gr/).
Mauro Comes Franchini received his degree in Industrial Chemistry at the University of Bologna in 1993 and PhD in Chemical Science, University of Bologna in 1996. Since from 1997 he is entitled with “Strategic Projects” CNR fellowship, later he becomes from 1998 as a researcher at the Faculty of Industrial Chemistry, Bologna. His International Experience is four months University of Nijmegen, The Netherlands, Dyson Perrins Laboratory and six months Oxford University, UK. He is the author of 87 articles published in international journals. Two WTO patents and 4 contributions to book's chapter and referee for several journals. He is the Member of the honorary editorial board of International Journal of Nanomedicine and the Member of the editorial board of Advances in Nanoparticles.
María de la Fuente Freire, a graduate in Pharmacy from the University of Santiago de Compostela (USC, 2001), completed her doctoral thesis in the Department of Pharmacy and Pharmaceutical Technology at the same institution (2001-2006), in the area of nano medicine and gene therapy. During this stage, she received two grants for predoctoral training, first from the Galician regional government (2001-2002), and then the Ministry of Education, FPU scholarship (2002-2006). She has also had two research residencies, one at the Institute of Applied Ophthalmology of the University of Valladolid (IOBA, 2003), and another at the University of Kuopio, Finland (2004). The results of her doctoral thesis led to her obtaining a PhD with European Doctorate accreditation, and her work was awarded the Prize for Best Doctoral Thesis “SPLC-CRS III and Eudragit Ph.D. Thesis Award”. In addition, she has generated several patents forming part of the intellectual property that led to the founding of the nano medicine division of Advancell S.L., in 2004.
Her post-doctoral training began at USC (2006-2007), as part of a project aimed at inhibiting invasion and metastasis processes, through the application of gene therapy and nanotechnology. Upon completion of this project, she moved to London (School of Pharmacy, University College of London, 2007-2011), participating in the preclinical development of nano-particle formulations, and the evaluation of new targets and therapeutic molecules for the treatment of tumours characterised by high aggressiveness (2007-2010). In addition, between 2008-2010 she was awarded a research grant by the Alfonso Martin Escudero Foundation. Part of her work during this stage was incorporated into the technology owned by the Nanomerics Ltd. spin-off. Her return to Spain was thanks to the Asociación Española Contra el Cáncer (Spanish Association Against Cancer), by whom she was made beneficiary of a contract for cancer researchers in the 2010 convocation.
In 2013, Dr. de la Fuente gained a Miguel Servet contract through competitive bidding, co-funded by the Carlos III Institute of Health (ISCIII) and the Galician Health Service (SERGAS), whose purpose is to incorporate doctors and translational research lines to public hospitals. With her research in therapeutic nano-oncology, nanotheranostics and translational processes to combat tumour spread and metastasis, she was integrated into the Translational Medical Oncology Group, where she directs the Laboratory of Nano-oncology and manages her own staff.
The scientific activity of Dr. de la Fuente is summarised in more than 35 publications in high impact journals, books, and book chapters. She participates in several European consortia, and is the principal researcher of two projects with national financing (ISCIII).
In the laboratory of Nano-oncology, the current team consists of the lead researcher and four researchers in predoctoral training stages. We also participate in the supervision of degree and masters final project work, and receive visiting researchers from other institutions.
Fabiana Arduini is Associate Professor at Department of Chemical Science and Technologies (Laboratory of Analytical Chemistry), University of Rome Tor Vergata . The research activity deals with the development of Bioassay and Biosensor systems, Electrochemical (bio)sensors, Electrochemical Mediators, Printed Electrodes, Sensors and Biosensors modified with Nanomaterials, Paper based (bio)sensors. The research activity was published in more than 80 articles in ISI peer-reviewed journals, among them with high impact factor in the analytical chemistry journal (e.g. Biosensor and Bioelectronics IF 8.173). H-index: 35, with 2814 total citations (Scopus, May 2019). She is author of more than 100 among poster and oral presentations at National and International congress, including plenary, keynotes and invited talk. She received in 2013 “Best Young Researcher” Award from the Analytical Chemistry Division of the Italian Chemical Society and in 2012 “Top cited author” for 2010-2011 on Biosensors and Bioelectronics journal (IF 6.451). She is the Coordinator of Interdivisional Sensor Group, Italian Chemical Society for the period 2019-2021. She is actually the Coordinator of European Project ERANETMED2-72-328 NanoSWS 2017-2020 “Integrated nanotechnologies for sustainable sensing water and sanitation”, BIAPTABONT project Ministry of Defence, INNOCONCRETE project within Executive Programme on Scientific and Technological Cooperation between Italian Republic and the Kingdom of Sweden for the years 2018-2020.
Gerard Tobias is a Research Scientist working at the Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), where he leads research on “Nanoengineering of carbon and inorganic materials”. He received Bachelor of Chemistry (with Honours) from the Autonomous University of Barcelona (UAB, 2000) and Ph.D. with European mention (UAB, ICMAB, 2004). He was a research visitor at Ames Laboratory (USA) and EMAT (Belgium). Between 2004 and 2009 he was a postdoctoral researcher in the group of Prof. Malcolm L.H. Green at the University of Oxford. He has coordinated the FP7 European network RADDEL and has been recently granted an ERC Consolidator Grant (NEST).